WallStreetZenWallStreetZen

NASDAQ: TVTX
Travere Therapeutics Inc Stock Ownership - Who owns Travere Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Travere Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gary A. LyonsDirector2026-08-18900$63.86
$57.47kSell
Gary A. LyonsDirector2026-08-184,100$63.27
$259.39kSell
Gary A. LyonsDirector2026-08-185,000$17.44
$87.20kBuy
Gary A. LyonsDirector2026-08-17500$64.16
$32.08kSell
Gary A. LyonsDirector2026-08-175,000$17.44
$87.20kBuy
Gary A. LyonsDirector2026-08-171,900$62.53
$118.81kSell
Gary A. LyonsDirector2026-08-172,600$63.50
$165.10kSell
Roy D. BaynesDirector2026-06-124,500$50.00
$225.00kSell
Timothy CoughlinDirector2026-06-1210,000$26.52
$265.20kBuy
Timothy CoughlinDirector2026-06-1210,000$50.08
$500.75kSell

1 of 13

TVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TVTX insiders and whales buy or sell their stock.

TVTX Shareholders

What type of owners hold Travere Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ruth Shepley51.98%49,000,000$3.16BInsider
Broadfin Healthcare Master Fund Ltd2.82%2,658,854$171.39MInsider
Opaleye GP LLC2.23%2,097,671$135.22MInsider
Martin Shkreli1.87%1,765,168$113.78MInsider
Eric M. Dube0.46%432,886$27.90MInsider
Marc L. Panoff0.23%221,100$14.25MInsider
Steve Aselage0.18%166,419$10.73MInsider
Alvin Shih0.17%158,334$10.21MInsider
Peter Heerma0.15%140,684$9.07MInsider
Christopher R. Cline0.13%118,658$7.65MInsider

1 of 3

TVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TVTX0.11%61.61%Net SellingNet Buying
DNTH0.12%60.34%Net BuyingNet Buying
ERAS0.08%24.59%Net Buying
KNSA0.06%10.37%Net SellingNet Selling
MIRM0.11%81.25%Net BuyingNet Selling
View Top Biotech Stocks

Travere Therapeutics Stock Ownership FAQ

Who owns Travere Therapeutics?

Travere Therapeutics (NASDAQ: TVTX) is owned by 0.11% institutional shareholders, 61.61% Travere Therapeutics insiders, and 38.27% retail investors. Ruth Shepley is the largest individual Travere Therapeutics shareholder, owning 49.00M shares representing 51.98% of the company. Ruth Shepley's Travere Therapeutics shares are currently valued at $3.22B.

If you're new to stock investing, here's how to buy Travere Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.